Therefore, the objective of this study is to create a dual-receptor-targeted peptide heterodimer probe that simultaneously targets SSTR2 and FAP, with the expectation of improving tumor detection sensitivity and extending tracer uptake and retention time. The gene discussed is SSTR2; the disease is neoplasm.